+ All Categories
Home > Business > Presentatie IWT TGO-infosessies

Presentatie IWT TGO-infosessies

Date post: 06-Jul-2015
Category:
Upload: fwijns
View: 3,305 times
Download: 1 times
Share this document with a friend
Description:
Presentatie IWT TGO-infosessies
44
agentschap voor Innovatie door Wetenschap en Technologie
Transcript
Page 1: Presentatie IWT TGO-infosessies

agentschap voor Innovatiedoor Wetenschap en Technologie

Page 2: Presentatie IWT TGO-infosessies

agentschap voor Innovatiedoor Wetenschap en Technologie

Transformational Medical Research -Transformationeel Geneeskundig Onderzoek -TGO

6 juli 2012

Katrien Swerts

Page 3: Presentatie IWT TGO-infosessies

3

Transformational Medical Research - TGO

Context

Transformational Medical Research – TGO

Key features TGO programme

Technicalities

Questions

Page 4: Presentatie IWT TGO-infosessies

4

Context TGO-programme

Recently, a remarkable progress has been made in the field of medical basic research. New discoveries do not always result in new, effective medicines.

Page 5: Presentatie IWT TGO-infosessies

5

Context TGO-programme

The classical drug development path (clinical phase I, II and III studies) may form an obstacle for the development of innovative therapeutics.

Long and expensive drug development process

0 1 3 3.5 5 7 9 12

Page 6: Presentatie IWT TGO-infosessies

6

Context TGO-programme

The classical drug development path (clinical phase I, II and III studies) may form an obstacle for the development of innovative therapeutics.

Low success rate

Page 7: Presentatie IWT TGO-infosessies

Context TGO-programme

Consequences: Patients need to wait for quite a long time before

new, sometimes lifesaving drugs reach the market. New drugs are quite expensive.

Increasing health care expenditures in Flanders, Belgium, Europe,…

Page 8: Presentatie IWT TGO-infosessies

8

Context TGO-programme

We need to reform the drug development process in order to speed up the development of innovative, more effective drugs. Bridge the ‘innovation gap’ Redesign clinical trials Implement biomakers in order to identify specific

target populations Increase the cost effectiveness of

the process …

Page 9: Presentatie IWT TGO-infosessies

9

Transformational Medical Research programme

The Flemish government (Min Ingrid Lieten) decided to step in and launch the Transformational Medical Research (TGO) programme: Accelerate development of more effective, safe and

affordable drugs Strengthen the Flemish biopharma cluster Make Flanders an attractive region for innovative

clinical trials Provide our society with access to the best

therapies …

Page 10: Presentatie IWT TGO-infosessies

10

Transformational Medical Research programme

The Flemish government (Min Ingrid Lieten) decided to step in and launch the Transformational Medical Research (TGO) programme: Budget Call 2012-2013: 10 million EUR. Call will be organised by IWT.

Page 11: Presentatie IWT TGO-infosessies

Key features TGO-programme

Key features of TGO-programme: Support relevant collaborations between

companies, research organizations and clinical centres

Focus on adaptive clinical research projects with an economic and social added value

A substantial contribution to the current state of the art is mandatory

Use of biomarkers and/or biological samples from biobanks is encouraged.

Page 12: Presentatie IWT TGO-infosessies

12

Key features TGO-programme

Key features of TGO-programme: Support relevant collaborations between

companies, research organizations and clinical centres

Page 13: Presentatie IWT TGO-infosessies

Consortium: Companies, research organisations and clinical centres. Consortium consists of at least one company and one research organisation.

13

Key features TGO-programme

Page 14: Presentatie IWT TGO-infosessies

Consortium: Companies, research organisations and clinical centres. Consortium consists of at least one company and one research organisation.

14

Key features TGO-programme

Balanced consortium

Page 15: Presentatie IWT TGO-infosessies

15

Key features TGO-programme

Key features of TGO-programme: Focus on adaptive clinical research trials with an

economic and social added value TGO projects have a double finality Important feature compared to other IWT

programmes (e.g. R&D, SBO-E versus SBO-M, TBM)

Reach a relevant social goal, bringing in industrial expertise

Page 16: Presentatie IWT TGO-infosessies

16

Key features TGO-programme

Key features of TGO-programme: Focus on adaptive clinical research trials with an

economic and social added value Substantial valorisation potential Economic valorisation in Flanders

Investments / Employment

Large utilisation of project results Impact on the Flemish health care situation Positive medical impact on a specific patient

population

Page 17: Presentatie IWT TGO-infosessies

17

Key features TGO-programme

Adaptive clinical trials:A clinical trial design that uses accumulating data to

decide on how to modify aspects of the study as it continues, without undermining the validity and integrity of the trial. (Gallo et al., 2006)

Size of cohort Clinical end points Dose Response criteria Inclusion criteria …

Page 18: Presentatie IWT TGO-infosessies

18

Key features TGO-programme

Adaptive clinical trials:

Page 19: Presentatie IWT TGO-infosessies

19

Key features TGO-programme

Key features of TGO-programme: A substantial contribution to the current state of

the art is mandatory

Knowledge creation is essential! Clinical Phase III trials without inventive

approach or clinical trials, focused on registration will not be funded.

Page 20: Presentatie IWT TGO-infosessies

20

Technicalities TGO-programme

IntegrationThe modules should form an integrated project.

AdditionalityConsortium approach should have an added value compared to individual R&D, SBO or TBM projects.

Page 21: Presentatie IWT TGO-infosessies

Intellectual property

Technicalities TGO-programme

Module 1Research and Development

Owner project resultsCompany

Research organisation

- Clinical centre

Subcontractor: Market price or cost + margin No IP rights

Research partner: Actual cost Participate in generated IP (Agreements should not hinder industrial valorisation)

Page 22: Presentatie IWT TGO-infosessies

Technicalities TGO-programme

Owner project results

Module 2Strategic

Basic Research

Research organisation

- Clinical centre

Transfer of results to companies / spin-off:

Market conform transfer Consortium partners do not have preferential access to the results. Interested companies may have a ‘right of first negotiation’. Revenues should be reinvested in R&D.

Transfer of results to social actors

Subcontractors: no IP rights

Page 23: Presentatie IWT TGO-infosessies

Technicalities TGO-programme

Owner project resultsResearch

organisation -

Clinical centre

No transfer of results to companies / spin-offs.

Industry is not interested in the project results

Subcontractors: no IP rights

Module 3Applied

Research

Intellectual property

Page 24: Presentatie IWT TGO-infosessies

Budget

Technicalities TGO-programme

Budget Module 1

Research and Development

Budget Module 2

Strategic Basic Research

Budget Module 3

Applied Research

Total project budget

Budget Company 1

Budget Company 2

Budget Research partner

Page 25: Presentatie IWT TGO-infosessies

Budget IWT cost model: see website: www.iwt.be

Technicalities TGO-programme

Payroll costs (human resources and real salary costs)

Other costsDirect costs

Indirect costs

Subcontractors

Page 26: Presentatie IWT TGO-infosessies

Subsidy Total project subsidy between 1.000.000 EUR and

3.500.000 EUR. Subsidy percentage differs per Module.

Technicalities TGO-programme

Page 27: Presentatie IWT TGO-infosessies

Subsidy

Technicalities TGO-programme

Module 1Research and Development

Module 2Strategic Basic

Research

Module 3Applied

Research

Research: 50% Development: 25% Adaptive clinical trials: 37,5% Phase I/II clinical trials: 25% Phase III / Registration: 0%

Research organisations: 100% Clinical centres: 100%

Research organisations: 100% Clinical centres: 100%

Page 28: Presentatie IWT TGO-infosessies

Evaluation procedure

28

Technicalities TGO-programme

Page 29: Presentatie IWT TGO-infosessies

Prior to submission2.Information meeting

Based on abstract (max. 2 pages) + specific questions

Topics to be discussed: Fit of project proposal Programme related issues (budget, eligibility

partners, etc.)

Interested? Contact IWT: [email protected]

Technicalities TGO-programme

Page 30: Presentatie IWT TGO-infosessies

Prior to submission2. Pre-registration meeting

Deadline: November 26th, 2012 Based on preliminary project proposal Topics to be discussed:

Consortium composition Project structure Valorisation Added value Budget Etc.

Interested? Contact IWT: [email protected]

Technicalities TGO-programme

Page 31: Presentatie IWT TGO-infosessies

Prior to submission2. Pre-registration meeting

IMPORTANT: First time right! No instruction meeting! Project proposals cannot be changed once they are

submitted.

Technicalities TGO-programme

Page 32: Presentatie IWT TGO-infosessies

Technicalities TGO-programme

Page 33: Presentatie IWT TGO-infosessies

Submission Electronic submission (E-mail [email protected] (max 10

MB) or CD-rom) Submission according to the template on the

website

Technicalities TGO-programme

Page 34: Presentatie IWT TGO-infosessies

Eligibility Formal eligibility criteria

(See TGO-manual for complete list) On time? According to template? Consortium composition Etc.

Decision: January 8th, 2013

Technicalities TGO-programme

Page 35: Presentatie IWT TGO-infosessies

Evaluation IWT consults at least 4 international experts per

project proposal Two general evaluation dimensions:

Quality Social and economic valorisation

Module specific criteria

Technicalities TGO-programme

Page 36: Presentatie IWT TGO-infosessies

Evaluation Quality

Project focuses on the development of more effective and affordable drugs

Contribution to the current state of the art Relevance of the scientific approach Risks and feasibility of the scientific approach Quality project plan Project management and track record Competence and infrastructure

Technicalities TGO-programme

Page 37: Presentatie IWT TGO-infosessies

Evaluation Social and economic valorisation

Valorisation potential and feasibility valorisation goals

Relevance project for valorisation goals Social impact of project results Economic impact of project results Competence and track record Broad utilisation Added value compared to existing IWT

programs

Technicalities TGO-programme

Page 38: Presentatie IWT TGO-infosessies

Evaluation Module specific criteria

Quality Social and economic valorisation

Technicalities TGO-programme

Page 39: Presentatie IWT TGO-infosessies

Evaluation Decision:

Meeting Board of Directors April 2013.

Technicalities TGO-programme

Page 40: Presentatie IWT TGO-infosessies

Tips and tricks Carefully read the documents on the website and

contact IWT in case of questions ([email protected]) Before you start writing your full proposal, send an

abstract of the proposal to [email protected] in order to get some feedback regarding the fit of your project in the program

Ask for a pre-registration meeting

Technicalities TGO-programme

Page 41: Presentatie IWT TGO-infosessies

Tips and tricks Make sure your project has a clear focus Make sure the project modules are integrated Make sure the scientific goals are in line with the

valorisation goals Go for an innovative approach (risk and added

value state of the art) Etc.

Technicalities TGO-programme

Page 42: Presentatie IWT TGO-infosessies

Timing:

42

Technicalities TGO-programme

Opening call June 2012

Submission deadline December 17th, 201212:00 (Noon)

Eligibility January 8th, 2013

Funding decision April 18th, 2013

Page 43: Presentatie IWT TGO-infosessies

More information:http://www.iwt.be/subsidies/tgo

[email protected]

IWT Team:Liesbeth BiesmansMia CallensHendrik De BondtPatricia MentenDirk VeelaertKatrien Swerts (Programme coordinator)Maarten Sileghem (Responsible director)

43

Technicalities TGO-programme

Page 44: Presentatie IWT TGO-infosessies

Koning Albert II-laan 35, bus 16B-1030 BrusselTel.: +32 (0)2 432 42 00Fax.: +32 (0)2 432 43 99E-mail: [email protected]

agentschap voor Innovatiedoor Wetenschap en Technologie


Recommended